01—Abstract
Summary
Summary of the 10-Q filed May 3, 2023. Cited figures are marked; the original filing is the authoritative source.
CME Group Inc. reported a strong first quarter of 2023, with total revenues increasing by 7% year-over-year to $1.44 billiona.
This growth was primarily driven by a 5% increase in clearing and transaction fees, which benefited from higher contract volumes and an increase in the average rate per contract due to a fee structure adjustment. Market data and information services also saw a solid 9% increase. Net income rose by a significant 24% to $883.8 millionb, translating to a 25% increase in diluted earnings per share to $2.43.
The company's operating margin remained robust at 63.4%c. A notable driver of the increased profitability was a substantial increase in investment income, primarily from reinvested performance bonds and guaranty fund contributions, which surged due to higher interest rates. While operating expenses also increased, driven by compensation, technology, and professional services, the revenue growth and improved non-operating income more than offset these increases.
02—Key points
Key Highlights
- Total revenues increased 7% to $1.44 billion in Q1 2023 compared to Q1 2022.
- Net income grew 24% to $883.8 million, and diluted EPS increased 25% to $2.43.
- Clearing and transaction fees rose 5% to $1.20 billion, driven by a 4% increase in contract volume and a 3% increase in average rate per contract.
- Interest rate product volume saw a significant 16% increase due to higher market volatility and the transition from LIBOR.
- Market data and information services revenue increased by 9%.
- Operating expenses increased 8% primarily due to higher compensation, technology, and professional services costs.
- Investment income experienced a substantial increase, contributing significantly to the quarter's profitability due to higher interest rates on reinvested performance bonds.
03—One dollar
04—Financials
Financial Highlights
Figures from 10-QQ1 FY2023filed May 3, 2023Financial Statements
Q1 FY2023 against Q1 FY2022
| Line item | Q1 FY2023Q1 FY2022 | Change |
|---|---|---|
| Revenue | $1.44B$1.35B | +7.1% |
| Operating Expenses | $527.90M$487.50M | +8.3% |
| Operating Income | $913.70M$859.10M | +6.4% |
| Net Income | $883.80M$711.00M | +24.3% |
| EPS (Basic) | $2.43$1.96 | +24.0% |
| EPS (Diluted) | $2.43$1.95 | +24.6% |
| Shares Outstanding (Basic) | 358.93M358.61M | +0.1% |
| Shares Outstanding (Diluted) | 359.31M359.18M | 0.0% |
05—Questions
Frequently Asked Questions
What were the main drivers of revenue growth in Q1 2023?
Revenue growth was primarily driven by an increase in clearing and transaction fees, which benefited from higher contract volumes (up 4%) and an improved average rate per contract (up 3%) due to fee structure adjustments. Market data and information services also contributed positively with a 9% increase.
How did market volatility impact CME Group's business in Q1 2023?
Increased volatility in interest rate and foreign exchange markets positively impacted contract volumes in those areas. Higher volatility in interest rates was driven by inflation concerns and regional bank stability issues, while increased foreign exchange volatility was linked to global economic uncertainty. Conversely, lower volatility in energy and agricultural markets led to decreased volumes in those segments compared to the prior year.
What led to the significant increase in investment income?
The substantial increase in investment income was primarily due to higher interest earned on reinvested cash performance bonds and guaranty fund contributions. This was a direct result of the rising interest rate environment in 2022 and early 2023.
Are there any significant ongoing legal or regulatory matters that investors should be aware of?
The company is involved in a putative class action lawsuit related to Class B shareholders and members, which was certified for damages in December 2021. While management believes it has strong defenses, the outcome and potential losses are currently unestimable. Other legal and regulatory matters are considered unlikely to have a material impact on the company's financial position or results of operations. No accrual has been made as matters are not probable and estimable.
06—Continue